Atlas Trials

Pilot Bioequivalence Study of Chiglitazar/Metformin Extended-Release Tablets

Clinical trial NCT07412015 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07412015
Sponsor
Chipscreen Biosciences, Ltd.
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
T2DM (Type 2 Diabetes Mellitus)
Start date
2026-05-27
Primary completion
2026-06-29
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.